ABUS - Arbutus Biopharma Corp
IEX Last Trade
3.88
0.050 1.289%
Share volume: 2,485,972
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.83
0.05
1.31%
Summary score
25%
Profitability
25%
Dept financing
7%
Liquidity
75%
Performance
18%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-16.31%
Return on assets
-10.85%
Return on sales
-594.85%
Return on invested capital
658.69%
Total debt ratio
25.72%
Debt ratio change over timeo
-1.23%
Current Ratio
9.47%
Quick Ratio
9.47%
Cash Position Ratio
9.09%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-15.84%
Return on assets
-12.8%
Return on sales
-769.04%
Return on invested capital
284.46%
Total debt ratio
24.73%
Debt ratio change over timeo
-0.91%
Current Ratio
6.35%
Quick Ratio
6.35%
Cash Position Ratio
6.05%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-15.59%
Return on assets
-12.76%
Return on sales
-1252.15%
Return on invested capital
304.1%
Total debt ratio
23.72%
Debt ratio change over time
-0.88%
Current Ratio
6.69%
Quick Ratio
6.69%
Cash Position Ratio
6.37%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-86.37%
Return on assets
-91.63%
Return on sales
302.67%
Return on invested capital
128.96%
Total debt ratio
-123.36%
Debt ratio change over time
-1.23%
Current Ratio
-11.87%
Quick Ratio
-11.87%
Cash Position Ratio
-11.42%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ABUS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -16.31% | 13.79% | 34.47% | 7.43% |
| Return on assets | -10.85% | 2.76% | 3.15% | 5.62% |
| Return on sales | -594.85% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 658.69% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 40% | 59% | 56% |
| Total debt ratio | 25.72% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.23% | 308.97% | -6.99% | 1.18% |
| Dept financing | 7% | 50% | 25% | 7% |
| Current Ratio | 6.35% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 6.35% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 6.05% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 5% | 12% | 27% |
| Short-term ratios | ABUS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -15.84% | 13.77% | 13.25% | 3.8% |
| Return on assets | -12.8% | 2.43% | 1.89% | 3.09% |
| Return on sales | -769.04% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 284.46% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 65% | 59% | 58% |
| Total debt ratio | 24.73% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.91% | 46.38% | -72.08% | 1.51% |
| Dept financing | 7% | 50% | 25% | 7% |
| Current Ratio | 6.35% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 6.35% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 6.05% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 8% | 21% | 52% |